NCT07777484RecruitingPhase 1
An unblinded, single arm, pilot observational study to test the safety, tolerability, immunogenicity and the biological effects of TRB-001 vaccination in individuals who have previously undergone aSyn immunotherapy
Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Jul 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (estimated)
- First submitted
- 18 Apr 2026
- Start date
- 28 Jul 2026
- Lead sponsor
- Tridem Bioscience FlexCo
- Diseases
- Parkinson disease
- EU CT number
- 2026-526294-42-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 8
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prosenex Ambulatorium BetriebsgmbH Coordinator of this site? Confirm its status | Vienna | Austria | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.